Loading clinical trials...
Loading clinical trials...
This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boehringer Ingelheim
NCT06498648 · Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, and more
NCT06422806 · Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, and more
NCT06389799 · Dedifferentiated Liposarcoma
NCT05694871 · Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, and more
NCT04967521 · Advanced Dedifferentiated Liposarcoma
Beijing Jishuitan hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions